|
|
 |
|
Viewing report
|
|
 |
 |
Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success
Best Practices LLC, May 2004, Pages: 56
In today's challenging healthcare environment, medical affairs' role has become even more crucial to pharmaceutical companies' success. Confronted with declining R&D productivity, escalating development costs, increasing competition, growing price pressures and intensified regulatory and public scrutiny, pharmaceutical companies seek to maintain double-digit revenue and earnings growth demanded by investors. In addition, companies are reallocating resources in response to Office of Inspector General (OIG) guidelines. This study uncovers how leading companies are working to align, staff and fund medical affairs capabilities to respond to these challenges.
Product samples
Executive Summary - Medical Affairs Excellence
Customers who bought this item also bought
Nipro Medical Device Company Intelligence Report
Smiths Medical Medical Device Company Intelligence Report
Datascope Medical Device Company Intelligence Report
Venture Funding in Healthcare Industry (2006) � A Market Study�
Medical Tourism - Global Strategic Business Report
The US Medical Transcription Industry: Perspective on Outsourcing and Offshoring
BioMed Outsourcing Report - Opportunities in Outsourcing Marketing, Regulatory and Downstream Services
Alternative Financial Solutions For Medical Technology Acquisition
|
 |
|
|